Application of Royalty Rates. All royalties set forth under Section 6.6 shall always be subject to the provisions of this Section 6.6.2, and shall only be payable as follows, on a Licensed Product-by-Licensed Product and country-by-country basis:
Appears in 3 contracts
Samples: Product Development and Commercialization Agreement (Regulus Therapeutics Inc.), Product Development and Commercialization Agreement (Regulus Therapeutics Inc.), Product Development and Commercialization Agreement (Isis Pharmaceuticals Inc)
Application of Royalty Rates. All royalties set forth payable under Section 6.6 this Article 6 shall always be subject to the provisions of this Section 6.6.2, 6.6.1 and shall only be payable as follows, follows and on a Licensed Product-by-Licensed Product and country-by-country basisbasis (subject to Section 6.6.1(g)). With respect to each Licensed Product:
Appears in 1 contract
Application of Royalty Rates. All royalties set forth under Section 6.6 shall always be 5.9.1 are subject to the provisions of this Section 6.6.25.9.2, and shall only will be payable as follows, on a Licensed Product-by-Licensed Product and country-by-country basis:
Appears in 1 contract
Samples: Development and License Agreement (Isis Pharmaceuticals Inc)
